On-Demand Webinars

BIO 2025: What You Missed – and What It Means for Biotech’s Future

Alcami Insights
BIO 2025
Biologics
Biotech Recap
CDMO
cell therapy
FDA
Pharma Manufacturing
Supply Chain

Couldn’t attend BIO this year? Or want to make sure you caught the biggest insights?

We’ve got you covered. Our expert panel of biotech insiders just wrapped a rapid-fire, insight-packed webinar breaking down the most talked-about moments from the BIO International Convention in Boston.
Watch the recap to explore:
  • The real impact of reshoring and supply chain shifts in the CDMO space
  • What’s next for biologics manufacturing and fill-finish capacity
  • How emerging modalities like TCR-T, XRNA, and in vivo cell therapies are reshaping the innovation pipeline
  • The ripple effects of FDA staffing cuts and evolving regulatory dynamics
  • Why precision, flexibility, and strategic CDMO partnerships are more critical than ever
Meet the Experts:
  • Gil Roth, President, Pharma & Biopharma Outsourcing Association
  • Tim Compton, Chief Strategy Officer, Alcami
  • Mark Farmery, Chief Development Officer, Anocca
  • Moderated by Elliot Berger, Board Director, Orientation Marketing
Featuring leaders from Alcami, Anocca, and the Pharma & Biopharma Outsourcing Association, this session delivers unfiltered insights from the front lines of biotech.

Watch on-demand now and stay ahead of what’s next.

"*" indicates required fields

Lookup*
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.*
Related Topics
Bio International
Unlocking the Future: Navigating the Next Phase of Biologics through the CDMO Lens
Contact Alcami
What do you want to know?
Some query